We have previously developed a recombinant adenovirus containing a fusion gene of Escherichia coli cytosine deaminase ( CD ) and herpes simplex virus type 1 thymidine kinase ( HSV -1 TK ) controlled by a cytomegalovirus ( CMV ) enhancer -promoter. This replication -incompetent adenovirus effectively transduced the CD -TK gene into human prostate adenocarcinoma DU -145 or PC -3 cells. Interestingly, heat shock at 418C for 4 hours elevated the level of CD -TK by approximately 5 -to 20 -fold at a multiplicity of infection ( MOI ) of 1. Heat -enhanced expression of CD -TK promoted cytotoxicity by 23 -, 9 -, or 47 -fold in the presence of 50 g / mL ganciclovir ( GCV ), 500 g / mL 5 -fluorocytosine ( 5 -FC ), or 50 g / mL GCV + 500 g / mL 5 -FC, respectively, at an MOI of 1. Moreover, there was an increase in radiosensitivity when adenovirus -infected cells were heated at 418C for 4 hours followed by irradiation in the presence of the prodrugs. Virus + heat + 1 g / mL GCV treatment increased radiosensitivity by a dose -modifying factor ( DMF ) of 2.2, whereas virus + heat + 10 g / mL 5 -FC exposure resulted in a DMF of 2.3. Radiosensitization was clearly enhanced as a result of combined prodrug exposure ( DMF = 4.4 ). Our results suggest that the efficiency in expression of suicide genes from an adenoviral vector used for cytotoxic anticancer therapy could be improved by combining heat treatment with radiation therapy.
D espite significant advances in the diagnosis and therapy for localized prostate cancer, the optimal management of this disease remains undefined. Although current treatments for prostate cancer including surgery, radiation or antihormonal therapy improve survival for patients with an early stage of the disease, 1 -3 patients who are diagnosed at more advanced stages or have recurrent prostate cancer suffer from inferior outcomes. The limitations of conventional cancer therapies are due to acceptable tolerance limits for critical, adjacent normal tissues or the development of a resistance to the previous therapies. 4 Several alternative therapies, such as cryosurgery, have been tried. 5 However, these therapies come with a high risk of side effects, particularly incontinence. Thus, in order to improve the efficacy of treatment, prostate cancer therapy may require innovative approaches for recurrent and advanced -stage prostate cancer. One such approach is suicide gene therapy, which involves the transfer and the expression of nonmammalian genes encoding enzymes that convert nontoxic prodrugs into toxic forms. In this paper, we have employed two toxin genes, E. coli cytosine deaminase (CD ) and herpes simplex virus type 1 thymidine kinase (HSV-1 TK ). The E. coli CD / HSV-TK converts the relatively nontoxic substrate 5 -fluorocytosine ( 5-FC ) and antiviral purine analog ganciclovir ( GCV ) to the highly toxic 5 -fluorouracil ( 5-FU ) and phosphorylated GCV, respectively. 6 -8 In addition, our previous studies and other researchers have demonstrated that these two toxic drugs cause bystander toxicity, which effectively kills neighboring cells, 9 and enhances radiosensitivity. 10 -14 Transduced cells that constitutively express the CD -TK fusion gene exhibit acute supra -additive sensitivity to combined GCV and 5 -FC treatment as well as enhanced radiosensitivity in the presence of both drugs. 11,15 -17 Moreover, cotreatment with HSV-1 TK -and E. coli CD -specific prodrugs may effectively overcome the acquired drug resistance, because tumor cells are unlikely to develop the resistance to both drugs. Thus, targeted transfer of these genes to prostate tumor combined with radiation may substantially improve the efficacy of prostate cancer therapy.
Current advances in targeted gene therapy open up new frontiers for molecular therapies of prostate cancer. However, inefficient gene delivery and the lack of tumor specificity represent two major hurdles in the development of a toxin -mediated gene therapy for prostate cancer. A novel approach with much potential is the use of hyperthermia. We have previously observed that hyperthermia effectively kills prostate cancer cells, which are inherently sensitive to heat shock. 18 Thermal stress also enhances radiation -induced cytotoxicity. 19 In this study, we observed that mild hyperthermia ( heating at 418C ), which is clinically achievable, enhanced cytomegalovirus (CMV ) promoterdriven toxin gene expression by 5-to 20 -fold in prostate cancer cells transduced by adenovirus. The findings reported in this paper may still not overcome the low delivery efficiency of therapeutic genes in vivo. However, our observations support the feasibility of hyperthermia to promote therapeutic gene expression and cytotoxicity in cells infected with the replication -incompetent virus.
Materials and methods

Cell culture
Human prostatic adenocarcinoma (DU -145 or PC -3 ) cells were used to examine the cytotoxic effects of CD -TK 
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Hyperthermia and adenoviral vector containing CMV promoter YJ Lee et al transduction and prodrug treatment. DU -145 or PC -3 cells were maintained in DMEM media (Gibco BRL, Gaithersburg, MD ) or RPMI media ( Gibco BRL ), respectively, containing 10% fetal bovine serum (FBS ). Infections with various multiplicities of infection ( MOIs ) of recombinant adenovirus were performed in DMEM media supplemented with 5% heat -inactivated horse serum for 16 hours. Drug exposure was performed by replacement of the viral inoculum with maintenance medium containing the prodrug( s) for 24 hours before plating for survival determination.
Recombinant adenoviral vector construction
A replication -incompetent adenoviral vector containing a CD -TK gene driven by the CMV enhancer -promoter ( Ad.CMV /CD -TK ) was constructed previously. 15 In brief, the CD -TK gene was cloned into the pcDNA3 vector ( Invitrogen, Carlsbad, CA ). The clone was digested with BglII and PvuII enzymes to remove the contiguous CMV promoter, CD -TK gene and bovine growth hormone polyadenylation sequences (BGHpA ) and cloned into pÁE1sp1B ( Microbix, Toronto, Canada ) at the BglII and EcoRV sites, to create pÁE1 /CMV-CDTK. The completed shuttle vector was cotransfected into 293 cells with viral plasmid pJM17. Adenovirus plaques were selected and analyzed. Virus growth, titration, and purification (by CsCl step gradient ) were performed as described previously. 20 
Western blotting
The expression of CD -TK protein in adenovirus infected cells was detected using sodium dodecyl sulfate (SDS )-PAGE gradient gels ( 10-18% ) and immunoblotting using a human HSV-1 TK monoclonal antibody (#4C8 ) provided by Dr W C Summers ( Yale University, New Haven, CT ) as described previously.
14 Proteins were visualized using the nonradioactive enhanced chemiluminescence ( ECL ) detection system (Amersham, Arlington Heights, IL ) and Fuji Xray film (Fuji Medical Systems, Stanford, CT). Quantitation of images was carried out by a scanning densitometer ( Bio Rad, Hercules, CA ).
Hyperthermic treatment and irradiation
Cells in T-25 flasks were heated by total immersion in a circulating water bath maintained within± 0.058C of the desired temperature. Cells were irradiated in the flask in a water bath at 378C with a GE Maximar 250-III orthovoltage X -ray unit (General Electric, Chicago, IL ) at a dose rate of 1.17 Gy /min. The tube voltage was 250 kVp, the current 15 mA, and added filtration of 0.25 -mm Cu.
Cell survival
The effects of adenoviral vector infection, drug exposure, hyperthermia, or irradiation on DU -145 cells were quantitated using clonogenic survival assays as previously described.
14 Approximately 5 -6Â10 5 cells were exposed to the virus at an MOI of 1 plaque -forming unit (pfu ) per cell. GCV and 5 -FC were used at a concentration of 2-10 and 20 -100 g /mL, respectively. The survival data were normalized by plating efficiency, hyperthermia, and virus effects.
Results
To examine the modulation of gene expression by heat shock, DU -145 cells were infected with a replication - Figure 1 . Western blot analysis shows that the infected cells, which did not receive heat shock, expressed low levels of CD -TK fusion protein ( Fig 2 ) . However, densitometric analyses illustrate that heat shock increased the expression 
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Hyperthermia and adenoviral vector containing CMV promoter YJ Lee et al enhanced the CMV promoter activity, promoted translation, or accumulated the transduced gene product over time in DU -145 cells. These observations were confirmed in another human prostatic adenocarcinoma cell line, PC -3 ( Fig 3 ) and murine cell line, L929. 21 Next we examined if heat -elevated expression of CD -TK could enhance the cytotoxicity effect by treatment with the prodrugs GCV and /or 5-FC. DU -145 cells were infected with the Ad.CMV /CD -TK (MOI= 1), and exposed to heat shock followed by GCV or 5-FC treatment. The experimental procedures are summarized in Figure 4 . Figure 5 shows that toxicities were observed for virally infected cells in the presence of either GCV (0.1-50 g/mL) or 5-FC ( 1-500 g /mL ). The toxicity was dependent on prodrug concentrations. Combined treatment (viral infection and hyperthermia ) effectively killed cells even at low concentrations of prodrugs (0.1 g /mL GCV or 1 g/mL 5-FC) ( Fig 5, A and B ) . These results demonstrated that expression of CD -TK successfully activated both prodrugs to toxic products in heated cells. Figure 5 also shows that a greater extent of killing was observed when virally infected cells were heated before drug exposure. For example, when the survival of heated cells was compared with that of unheated cells, approximately 23 -, 7 -, or 47 -fold increase in drug toxicity was observed in the presence of 50 g /mL GCV, 500 g /mL 5 -FC, or 50 g /mL GCV + 500 g/ mL 5 -FC, respectively.
To determine if adenovirus containing CD -TK, heat, and prodrug exposure could enhance radiosensitivity, DU -145 cells were infected with Ad.CMV / CD -TK (MOI= 1 ) for 16 hours, followed by heat shock at 418C for 4 hours. After heat shock, the cells were incubated at 378C for 24 hours and then treated with the prodrugs (1 g /mL GCV or 10 g/mL 5 -FC ) for an additional 24 hours. The cells were then exposed to various doses of X -irradiation before plating for survival determination. The experimental procedures are summarized in Figure 6 . Treatment with virus alone did not result in significant toxicity at an MOI of 1 ( 94± 10% ). There was no significant toxicity when DU -145 cells were only heated at 418C for 4 hours (95 ± 3.6% ). Figure 7A shows that there was no hyperthermia effect on radiosensitivity. There was also no viral effect on radiosensitivity at a low dose of radiation ( 2 or 4 Gy ). However, there was an increase in radiocytotoxicity when virally infected or virus + heated cells were irradiated at a high dose of radiation ( 6 or 8 Gy ). A dose -modifying factor ( DMF, control radiation dose / experimental dose required to achieve an isosurvival of 10 À 2 ) for this group was 1.38. Figure 7B shows at an isosurvival of 10 À 2 , the exposure to virus and 1 g/ mL GCV or 10 g/ mL 5-FC enhanced radiation sensitivity by a DMF of approximately 1.33 or 1.77, respectively. These results suggest that both prodrugs enhanced radiosensitivity in viral vector -infected cells. However, there is no difference between virus and virus plus GCV with radiation, at least at 2, 4, and 6 Gy. This is probably due to a low level of CD -TK expression at a low MOI. However, when viral vector-infected cells were heated at 418C for 4 hours and treated with prodrugs, they became significantly sensitive to radiation ( Fig 7C ) . Virus + heat + 1 g/ mL GCV treatment increased radiosensitivity by a DMF of 2.3, whereas virus + heat + 10 g /mL 5 -FC exposure resulted in a DMF of 2.4. When cells were treated with both prodrugs (1 g/mL GCV + 10 g /mL 5-FC ), radiosensitization was clearly enhanced (DMF =4.4 ).
Discussion
Our studies demonstrated that hyperthermia enhances CMV promoter -driven E. coli CD and HSV-1 TK fusion gene expression in a recombinant adenovirus vector. The CD -TK gene product activates prodrugs 5 -FC and GCV and subsequently generates cytotoxicity as well as radiosensitization.
Previous studies have shown that CD deaminates 5 -FC to 5 -FU. 22 5-FU is metabolized to 5 -fluorouridine 5 0 -triphosphate ( 5-FUTP ). 5 -FUTP inhibits nuclear processing of rRNA and mRNAs. 5-FU is also metabolized to 5 -fluoro -2 0 -deoxyuridine 5 0 -monophosphate (5 -FdUMP ). 5-FdUMP irreversibly inhibits thymidylate synthase (TS ) and subsequently DNA synthesis. 23 Cells treated with 5 -FU accumulate in early S phase, which is a radiosensitive phase of the cell cycle. 24 -27 Unlike mammalian thymidine kinase, HSV-1 TK can phosphorylate GCV. The monophosphate form of GCV is subsequently phosphorylated by endogenous cellular kinases to triphosphate form. This molecule inhibits DNA polymerase and subsequently prevents DNA replication. 28 The radiosensitization effect of the CD /5 -FC combination may be due to accumulation of cells in early S phase and increase in DNA strand breakage. In contrast, that of the HSV-1 TK /GCV combination is probably due to the inhibition of the repair of potentially lethal damage. 11 Thus, following double prodrug treatment, CD -TK expressing cells suffer increased DNA strand breakage by ionizing radiation ( due to the CD /5 -FC system ) and concomitantly are unable to replicate and repair DNA (due to the HSV-1 TK /GCV system ).
Several researchers have demonstrated that hyperthermia enhances radiation -induced cell death. 29 This radiosensitization is probably due to the loss of cellular DNA polymerase activity by heat shock. 30 The synergistic interaction between two different modalities is maximal when cells are irradiated during heating. 31 However, when the time interval between the two treatments is increased, the potentiated effect is rapidly reduced within 1 hour. 31 In our study, adenovirus -infected cells were irradiated 48 hours after heat treatment ( virus +heat in Fig 7A ) . Although heatinduced radiosensitization was not expected, we observed an increase in cell death by radiation. At this time, we can only speculate on how the combination of viral infection, heat, and prodrug treatment enhances radiation -induced cytotoxicity. Previous studies have demonstrated an interaction between radiation and adenovirus -mediated gene delivery, suggesting that pre -irradiation promotes adenoviral transduction efficiency. 32 The defective viral infection in combination with radiation may also contribute to the combinatory cytotoxicity through preferential synthesis of viral components and inhibition of host protein synthesis. 33 Obviously, further studies at the biochemical level are necessary to understand the possible interaction between radiation and viral infection. Nonetheless, our results clearly demonstrated that there was a substantial increase in radiocytotoxicity even at 2 Gy when viral vector -infected cells were heated and treated with prodrugs before radiation ( Fig 4C ) . Since patients are typically treated with doses 2 Gy, our observations suggest that the combinatory therapy with therapeutic gene, hyperthermia, and radiation will improve the efficacy of clinical cancer therapy.
Another question that remains to be answered is how heat shock enhances CD -TK gene expression. One possibility is that heat shock promotes the adenoviral vector infection process. However, cells were incubated with the viral vector for 16 hours before heat shock. Our preliminary data illustrate that the adenoviral vector infection process requires only a few hours ( 3-4 hours ) ( data not shown ). Thus, hyperthermia does not likely facilitate the viral vector infection process. Another possibility is that heat shock increases transcriptional activity, translational activity, or protein stability. Previous studies have shown that total protein synthesis except heat shock protein synthesis is inhibited during hyperthermia. 34 Nonetheless, heat shock enhances the CMV promoter -driven gene product as well as its mRNA level, 18, 35 which open up the possibility of stimulating CMV promoter rather than facilitating protein synthesis by heat shock. Previous studies have demonstrated that stress -induced denatured, unfolded, or malfolded proteins trigger the activation of heat shock transcription factors ( HSFs ). 36 The activated HSF binds to the heat shock element (HSE ), which is a conserved motif present in the promoters of heat shock protein genes. However, the CMV promoter does not contain the HSE. Therefore, it is possible that heat shock activates different types of transcription factors other than HSF to enhance CMV promoter activity. It should be pointed out that a nonclassical heat shock element has been described in yeast and perhaps a similar mechanism is at work in the infected DU145 cells. 37 Further experiments are currently underway to determine the mechanism for the hyperthermia -enhanced expression from the CMV promoter.
